{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:26:22Z","timestamp":1772119582556,"version":"3.50.1"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T00:00:00Z","timestamp":1721174400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T00:00:00Z","timestamp":1721174400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100001320","name":"Roswell Park Comprehensive Cancer Center","doi-asserted-by":"publisher","award":["P30CA016056"],"award-info":[{"award-number":["P30CA016056"]}],"id":[{"id":"10.13039\/100001320","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R37CA248018"],"award-info":[{"award-number":["R37CA248018"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-19-1-0674"],"award-info":[{"award-number":["W81XWH-19-1-0674"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009898","name":"Defense Health Agency","doi-asserted-by":"publisher","award":["W81XWH-19-1-0111"],"award-info":[{"award-number":["W81XWH-19-1-0111"]}],"id":[{"id":"10.13039\/100009898","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Rotary club","award":["District 2830"],"award-info":[{"award-number":["District 2830"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1007\/s10549-024-07434-3","type":"journal-article","created":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T03:02:38Z","timestamp":1721185358000},"page":"415-427","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["CD133 expression is associated with less DNA repair, better response to chemotherapy and survival in ER-positive\/HER2-negative breast cancer"],"prefix":"10.1007","volume":"208","author":[{"given":"Takumi","family":"Sato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Oshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing Li","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohei","family":"Chida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arya Mariam","family":"Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itaru","family":"Endo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuaki","family":"Takabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,17]]},"reference":[{"key":"7434_CR1","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.3389\/fimmu.2020.01280","volume":"11","author":"L Walcher","year":"2020","unstructured":"Walcher L, Kistenmacher AK, Suo H, Kitte R, Dluczek S, Strauss A, Blaudszun AR, Yevsa T, Fricke S, Kossatz-Boehlert U (2020) cancer stem cells-origins and biomarkers: perspectives for targeted personalized therapies. Front Immunol 11:1280. https:\/\/doi.org\/10.3389\/fimmu.2020.01280","journal-title":"Front Immunol"},{"key":"7434_CR2","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.biocel.2018.12.001","volume":"107","author":"R Butti","year":"2019","unstructured":"Butti R, Gunasekaran VP, Kumar TVS, Banerjee P, Kundu GC (2019) Breast cancer stem cells: biology and therapeutic implications. Int J Biochem Cell Biol 107:38\u201352. https:\/\/doi.org\/10.1016\/j.biocel.2018.12.001","journal-title":"Int J Biochem Cell Biol"},{"issue":"22","key":"7434_CR3","doi-asserted-by":"publisher","first-page":"7856","DOI":"10.1039\/d0cs00379d","volume":"49","author":"J Han","year":"2020","unstructured":"Han J, Won M, Kim JH, Jung E, Min K, Jangili P, Kim JS (2020) Cancer stem cell-targeted bio-imaging and chemotherapeutic perspective. Chem Soc Rev 49(22):7856\u20137878. https:\/\/doi.org\/10.1039\/d0cs00379d","journal-title":"Chem Soc Rev"},{"issue":"7","key":"7434_CR4","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.1073\/pnas.0530291100","volume":"100","author":"M Al-Hajj","year":"2003","unstructured":"Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci 100(7):3983\u20133988. https:\/\/doi.org\/10.1073\/pnas.0530291100","journal-title":"Proc Natl Acad Sci"},{"issue":"3","key":"7434_CR5","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.humpath.2011.05.005","volume":"43","author":"MO Idowu","year":"2012","unstructured":"Idowu MO, Kmieciak M, Dumur C, Burton RS, Grimes MM, Powers CN, Manjili MH (2012) CD44(+)\/CD24(\u2212\/low) cancer stem\/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome. Hum Pathol 43(3):364\u2013373. https:\/\/doi.org\/10.1016\/j.humpath.2011.05.005","journal-title":"Hum Pathol"},{"issue":"1","key":"7434_CR6","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41392-020-0110-5","volume":"5","author":"L Yang","year":"2020","unstructured":"Yang L, Shi P, Zhao G, Xu J, Peng W, Zhang J, Zhang G, Wang X, Dong Z, Chen F, Cui H (2020) Targeting cancer stem cell pathways for cancer therapy. Signal Transduct Target Ther 5(1):8. https:\/\/doi.org\/10.1038\/s41392-020-0110-5","journal-title":"Signal Transduct Target Ther"},{"key":"7434_CR7","doi-asserted-by":"publisher","first-page":"2561726","DOI":"10.1155\/2020\/2561726","volume":"2020","author":"MA Elbaiomy","year":"2020","unstructured":"Elbaiomy MA, Akl T, Atwan N, Elsayed AA, Elzaafarany M, Shamaa S (2020) Clinical impact of breast cancer stem cells in metastatic breast cancer patients. J Oncol 2020:2561726. https:\/\/doi.org\/10.1155\/2020\/2561726","journal-title":"J Oncol"},{"issue":"6","key":"7434_CR8","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.molcel.2017.05.015","volume":"66","author":"AN Blackford","year":"2017","unstructured":"Blackford AN, Jackson SP (2017) ATM, ATR, and DNA-PK: the trinity at the heart of the DNA damage response. Mol Cell 66(6):801\u2013817. https:\/\/doi.org\/10.1016\/j.molcel.2017.05.015","journal-title":"Mol Cell"},{"key":"7434_CR9","doi-asserted-by":"publisher","DOI":"10.21037\/sci.2017.10.03","author":"P Xia","year":"2017","unstructured":"Xia P (2017) CD133 mRNA may be a suitable prognostic marker for human breast cancer. Stem Cell Investig. https:\/\/doi.org\/10.21037\/sci.2017.10.03","journal-title":"Stem Cell Investig"},{"issue":"12","key":"7434_CR10","doi-asserted-by":"publisher","first-page":"4234","DOI":"10.1158\/1078-0432.CCR-08-1479","volume":"15","author":"T Tanei","year":"2009","unstructured":"Tanei T, Morimoto K, Shimazu K, Kim SJ, Tanji Y, Taguchi T, Tamaki Y, Noguchi S (2009) Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential paclitaxel and epirubicin-based chemotherapy for breast cancers. Clin Cancer Res 15(12):4234\u20134241. https:\/\/doi.org\/10.1158\/1078-0432.CCR-08-1479","journal-title":"Clin Cancer Res"},{"issue":"5","key":"7434_CR11","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.stem.2007.08.014","volume":"1","author":"C Ginestier","year":"2007","unstructured":"Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M, Jacquemier J, Viens P, Kleer CG, Liu S, Schott A, Hayes D, Birnbaum D, Wicha MS, Dontu G (2007) ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1(5):555\u2013567. https:\/\/doi.org\/10.1016\/j.stem.2007.08.014","journal-title":"Cell Stem Cell"},{"issue":"3","key":"7434_CR12","doi-asserted-by":"publisher","first-page":"R53","DOI":"10.1186\/bcr2108","volume":"10","author":"G Honeth","year":"2008","unstructured":"Honeth G, Bendahl PO, Ringner M, Saal LH, Gruvberger-Saal SK, Lovgren K, Grabau D, Ferno M, Borg A, Hegardt C (2008) The CD44+\/CD24\u2212 phenotype is enriched in basal-like breast tumors. Breast Cancer Res 10(3):R53. https:\/\/doi.org\/10.1186\/bcr2108","journal-title":"Breast Cancer Res"},{"issue":"10","key":"7434_CR13","first-page":"5141","volume":"11","author":"JL Huang","year":"2021","unstructured":"Huang JL, Oshi M, Endo I, Takabe K (2021) Clinical relevance of stem cell surface markers CD133, CD24, and CD44 in colorectal cancer. Am J Cancer Res 11(10):5141\u20135154","journal-title":"Am J Cancer Res"},{"issue":"3","key":"7434_CR14","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1080\/1061186X.2018.1479756","volume":"27","author":"A Barzegar Behrooz","year":"2019","unstructured":"Barzegar Behrooz A, Syahir A, Ahmad S (2019) CD133: beyond a cancer stem cell biomarker. J Drug Target 27(3):257\u2013269. https:\/\/doi.org\/10.1080\/1061186X.2018.1479756","journal-title":"J Drug Target"},{"issue":"2","key":"7434_CR15","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1002\/cbin.11243","volume":"44","author":"M Akbari","year":"2020","unstructured":"Akbari M, Shomali N, Faraji A, Shanehbandi D, Asadi M, Mokhtarzadeh A, Shabani A, Baradaran B (2020) CD133: an emerging prognostic factor and therapeutic target in colorectal cancer. Cell Biol Int 44(2):368\u2013380. https:\/\/doi.org\/10.1002\/cbin.11243","journal-title":"Cell Biol Int"},{"issue":"9","key":"7434_CR16","doi-asserted-by":"publisher","first-page":"e45865","DOI":"10.1371\/journal.pone.0045865","volume":"7","author":"N Aomatsu","year":"2012","unstructured":"Aomatsu N, Yashiro M, Kashiwagi S, Takashima T, Ishikawa T, Ohsawa M, Wakasa K, Hirakawa K (2012) CD133 is a useful surrogate marker for predicting chemosensitivity to neoadjuvant chemotherapy in breast cancer. PLoS ONE 7(9):e45865. https:\/\/doi.org\/10.1371\/journal.pone.0045865","journal-title":"PLoS ONE"},{"issue":"2","key":"7434_CR17","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s10549-018-05085-9","volume":"174","author":"C Joseph","year":"2019","unstructured":"Joseph C, Arshad M, Kurozomi S, Althobiti M, Miligy IM, Al-Izzi S, Toss MS, Goh FQ, Johnston SJ, Martin SG, Ellis IO, Mongan NP, Green AR, Rakha EA (2019) Overexpression of the cancer stem cell marker CD133 confers a poor prognosis in invasive breast cancer. Breast Cancer Res Treat 174(2):387\u2013399. https:\/\/doi.org\/10.1007\/s10549-018-05085-9","journal-title":"Breast Cancer Res Treat"},{"key":"7434_CR18","doi-asserted-by":"publisher","first-page":"7512632","DOI":"10.1155\/2019\/7512632","volume":"2019","author":"F Brugnoli","year":"2019","unstructured":"Brugnoli F, Grassilli S, Al-Qassab Y, Capitani S, Bertagnolo V (2019) CD133 in breast cancer cells: more than a stem cell marker. J Oncol 2019:7512632. https:\/\/doi.org\/10.1155\/2019\/7512632","journal-title":"J Oncol"},{"issue":"8","key":"7434_CR19","doi-asserted-by":"publisher","first-page":"559","DOI":"10.2174\/1568009620666200506110850","volume":"20","author":"M Kumari","year":"2020","unstructured":"Kumari M, Krishnamurthy PT, Sola P (2020) Targeted drug therapy to overcome chemoresistance in triple-negative breast cancer. Curr Cancer Drug Targets 20(8):559\u2013572. https:\/\/doi.org\/10.2174\/1568009620666200506110850","journal-title":"Curr Cancer Drug Targets"},{"issue":"5","key":"7434_CR20","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1111\/j.1349-7006.2011.01894.x","volume":"102","author":"P Zhao","year":"2011","unstructured":"Zhao P, Lu Y, Jiang X, Li X (2011) Clinicopathological significance and prognostic value of CD133 expression in triple-negative breast carcinoma. Cancer Sci 102(5):1107\u20131111. https:\/\/doi.org\/10.1111\/j.1349-7006.2011.01894.x","journal-title":"Cancer Sci"},{"issue":"1","key":"7434_CR21","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.ajpath.2012.03.019","volume":"181","author":"N Kagara","year":"2012","unstructured":"Kagara N, Huynh KT, Kuo C, Okano H, Sim MS, Elashoff D, Chong K, Giuliano AE, Hoon DS (2012) Epigenetic regulation of cancer stem cell genes in triple-negative breast cancer. Am J Pathol 181(1):257\u2013267. https:\/\/doi.org\/10.1016\/j.ajpath.2012.03.019","journal-title":"Am J Pathol"},{"issue":"5","key":"7434_CR22","doi-asserted-by":"publisher","first-page":"e245","DOI":"10.1177\/030089161309900523","volume":"99","author":"M Cantile","year":"2013","unstructured":"Cantile M, Collina F, D\u2019Aiuto M, Rinaldo M, Pirozzi G, Borsellino C, Franco R, Botti G, Di Bonito M (2013) Nuclear localization of cancer stem cell marker CD133 in triple-negative breast cancer: a case report. Tumori 99(5):e245-250. https:\/\/doi.org\/10.1177\/030089161309900523","journal-title":"Tumori"},{"issue":"10","key":"7434_CR23","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1002\/ijc.28263","volume":"133","author":"R Nadal","year":"2013","unstructured":"Nadal R, Ortega FG, Salido M, Lorente JA, Rodriguez-Rivera M, Delgado-Rodriguez M, Macia M, Fernandez A, Corominas JM, Garcia-Puche JL, Sanchez-Rovira P, Sole F, Serrano MJ (2013) CD133 expression in circulating tumor cells from breast cancer patients: potential role in resistance to chemotherapy. Int J Cancer 133(10):2398\u20132407. https:\/\/doi.org\/10.1002\/ijc.28263","journal-title":"Int J Cancer"},{"key":"7434_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13174443","author":"A Patel","year":"2021","unstructured":"Patel A, Oshi M, Yan L, Matsuyama R, Endo I, Takabe K (2021) The unfolded protein response is associated with cancer proliferation and worse survival in hepatocellular carcinoma. Cancers. https:\/\/doi.org\/10.3390\/cancers13174443","journal-title":"Cancers"},{"issue":"1","key":"7434_CR25","doi-asserted-by":"publisher","first-page":"16942","DOI":"10.1038\/s41598-019-53482-x","volume":"9","author":"T Takeshita","year":"2019","unstructured":"Takeshita T, Yan L, Asaoka M, Rashid O, Takabe K (2019) Late recurrence of breast cancer is associated with pro-cancerous immune microenvironment in the primary tumor. Sci Rep 9(1):16942. https:\/\/doi.org\/10.1038\/s41598-019-53482-x","journal-title":"Sci Rep"},{"key":"7434_CR26","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.canlet.2020.05.026","volume":"488","author":"A Ferrer","year":"2020","unstructured":"Ferrer A, Roser CT, El-Far MH, Savanur VH, Eljarrah A, Gergues M, Kra JA, Etchegaray JP, Rameshwar P (2020) Hypoxia-mediated changes in bone marrow microenvironment in breast cancer dormancy. Cancer Lett 488:9\u201317. https:\/\/doi.org\/10.1016\/j.canlet.2020.05.026","journal-title":"Cancer Lett"},{"issue":"10","key":"7434_CR27","first-page":"4840","volume":"12","author":"M Oshi","year":"2022","unstructured":"Oshi M, Tokumaru Y, Benesch MG, Sugito N, Wu R, Yan L, Yamada A, Chishima T, Ishikawa T, Endo I, Takabe K (2022) High miR-99b expression is associated with cell proliferation and worse patient outcomes in breast cancer. Am J Cancer Res 12(10):4840\u20134852","journal-title":"Am J Cancer Res"},{"issue":"1","key":"7434_CR28","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s10549-022-06552-0","volume":"193","author":"R Wu","year":"2022","unstructured":"Wu R, Patel A, Tokumaru Y, Asaoka M, Oshi M, Yan L, Ishikawa T, Takabe K (2022) High RAD51 gene expression is associated with aggressive biology and with poor survival in breast cancer. Breast Cancer Res Treat 193(1):49\u201363. https:\/\/doi.org\/10.1007\/s10549-022-06552-0","journal-title":"Breast Cancer Res Treat"},{"key":"7434_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14122962","author":"R Wu","year":"2022","unstructured":"Wu R, Roy AM, Tokumaru Y, Gandhi S, Asaoka M, Oshi M, Yan L, Ishikawa T, Takabe K (2022) NR2F1, a Tumor dormancy marker, is expressed predominantly in cancer-associated fibroblasts and is associated with suppressed breast cancer cell proliferation. Cancers. https:\/\/doi.org\/10.3390\/cancers14122962","journal-title":"Cancers"},{"issue":"1","key":"7434_CR30","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s10549-022-06661-w","volume":"195","author":"R Wu","year":"2022","unstructured":"Wu R, Gandhi S, Tokumaru Y, Asaoka M, Oshi M, Yan L, Ishikawa T, Takabe K (2022) Intratumoral PDGFB gene predominantly expressed in endothelial cells is associated with angiogenesis and lymphangiogenesis, but not with metastasis in breast cancer. Breast Cancer Res Treat 195(1):17\u201331. https:\/\/doi.org\/10.1007\/s10549-022-06661-w","journal-title":"Breast Cancer Res Treat"},{"issue":"7403","key":"7434_CR31","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nature10983","volume":"486","author":"C Curtis","year":"2012","unstructured":"Curtis C, Shah SP, Chin SF, Turashvili G, Rueda OM, Dunning MJ, Speed D, Lynch AG, Samarajiwa S, Yuan Y, Gr\u00e4f S, Ha G, Haffari G, Bashashati A, Russell R, McKinney S, Langer\u00f8d A, Green A, Provenzano E, Wishart G, Pinder S, Watson P, Markowetz F, Murphy L, Ellis I, Purushotham A, B\u00f8rresen-Dale AL, Brenton JD, Tavar\u00e9 S, Caldas C, Aparicio S (2012) The genomic and transcriptomic architecture of 2000 breast tumours reveals novel subgroups. Nature 486(7403):346\u2013352. https:\/\/doi.org\/10.1038\/nature10983","journal-title":"Nature"},{"key":"7434_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12103038","author":"M Oshi","year":"2020","unstructured":"Oshi M, Asaoka M, Tokumaru Y, Angarita FA, Yan L, Matsuyama R, Zsiros E, Ishikawa T, Endo I, Takabe K (2020) Abundance of regulatory T Cell (Treg) as a predictive biomarker for neoadjuvant chemotherapy in triple-negative breast cancer. Cancers. https:\/\/doi.org\/10.3390\/cancers12103038","journal-title":"Cancers"},{"key":"7434_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21186968","author":"M Oshi","year":"2020","unstructured":"Oshi M, Asaoka M, Tokumaru Y, Yan L, Matsuyama R, Ishikawa T, Endo I, Takabe K (2020) CD8 T cell score as a prognostic biomarker for triple negative breast cancer. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21186968","journal-title":"Int J Mol Sci"},{"key":"7434_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/cells9071643","author":"M Oshi","year":"2020","unstructured":"Oshi M, Takahashi H, Tokumaru Y, Yan L, Rashid OM, Nagahashi M, Matsuyama R, Endo I, Takabe K (2020) The E2F pathway score as a predictive biomarker of response to neoadjuvant therapy in ER+\/HER2\u2212 breast cancer. Cells. https:\/\/doi.org\/10.3390\/cells9071643","journal-title":"Cells"},{"key":"7434_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21082921","author":"M Oshi","year":"2020","unstructured":"Oshi M, Takahashi H, Tokumaru Y, Yan L, Rashid OM, Matsuyama R, Endo I, Takabe K (2020) G2M cell cycle pathway score as a prognostic biomarker of metastasis in estrogen receptor (ER)-positive breast cancer. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21082921","journal-title":"Int J Mol Sci"},{"key":"7434_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12102871","author":"M Oshi","year":"2020","unstructured":"Oshi M, Newman S, Tokumaru Y, Yan L, Matsuyama R, Endo I, Katz MHG, Takabe K (2020) High G2M pathway score pancreatic cancer is associated with worse survival, particularly after margin-positive (R1 or R2) resection. Cancers. https:\/\/doi.org\/10.3390\/cancers12102871","journal-title":"Cancers"},{"key":"7434_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21186708","author":"M Oshi","year":"2020","unstructured":"Oshi M, Newman S, Tokumaru Y, Yan L, Matsuyama R, Endo I, Nagahashi M, Takabe K (2020) Intra-tumoral angiogenesis is associated with inflammation, immune reaction and metastatic recurrence in breast cancer. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21186708","journal-title":"Int J Mol Sci"},{"key":"7434_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21165744","author":"Y Tokumaru","year":"2020","unstructured":"Tokumaru Y, Oshi M, Katsuta E, Yan L, Huang JL, Nagahashi M, Matsuhashi N, Futamura M, Yoshida K, Takabe K (2020) Intratumoral adipocyte-high breast cancer enrich for metastatic and inflammation-related pathways but associated with less cancer cell proliferation. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21165744","journal-title":"Int J Mol Sci"},{"key":"7434_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12102758","author":"M Oshi","year":"2020","unstructured":"Oshi M, Newman S, Murthy V, Tokumaru Y, Yan L, Matsuyama R, Endo I, Takabe K (2020) ITPKC as a prognostic and predictive biomarker of neoadjuvant chemotherapy for triple negative breast cancer. Cancers. https:\/\/doi.org\/10.3390\/cancers12102758","journal-title":"Cancers"},{"issue":"1","key":"7434_CR40","doi-asserted-by":"publisher","first-page":"16554","DOI":"10.1038\/s41598-020-73624-w","volume":"10","author":"M Oshi","year":"2020","unstructured":"Oshi M, Tokumaru Y, Asaoka M, Yan L, Satyananda V, Matsuyama R, Matsuhashi N, Futamura M, Ishikawa T, Yoshida K, Endo I, Takabe K (2020) M1 macrophage and M1\/M2 ratio defined by transcriptomic signatures resemble only part of their conventional clinical characteristics in breast cancer. Sci Rep 10(1):16554. https:\/\/doi.org\/10.1038\/s41598-020-73624-w","journal-title":"Sci Rep"},{"issue":"2","key":"7434_CR41","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.surg.2019.04.011","volume":"166","author":"H Takahashi","year":"2019","unstructured":"Takahashi H, Katsuta E, Yan L, Dasgupta S, Takabe K (2019) High expression of annexin A2 is associated with DNA repair, metabolic alteration, and worse survival in pancreatic ductal adenocarcinoma. Surgery 166(2):150\u2013156. https:\/\/doi.org\/10.1016\/j.surg.2019.04.011","journal-title":"Surgery"},{"issue":"7418","key":"7434_CR42","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/nature11412","volume":"490","author":"N Cancer Genome Atlas","year":"2012","unstructured":"Cancer Genome Atlas N (2012) Comprehensive molecular portraits of human breast tumours. Nature 490(7418):61\u201370. https:\/\/doi.org\/10.1038\/nature11412","journal-title":"Nature"},{"issue":"5","key":"7434_CR43","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, Antipin Y, Reva B, Goldberg AP, Sander C, Schultz N (2012) The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2(5):401\u2013404. https:\/\/doi.org\/10.1158\/2159-8290.CD-12-0095","journal-title":"Cancer Discov"},{"key":"7434_CR44","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2004088","author":"J Gao","year":"2013","unstructured":"Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, Cerami E, Sander C, Schultz N (2013) Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. https:\/\/doi.org\/10.1126\/scisignal.2004088","journal-title":"Sci Signal"},{"issue":"18","key":"7434_CR45","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1001\/jama.2011.593","volume":"305","author":"C Hatzis","year":"2011","unstructured":"Hatzis C, Pusztai L, Valero V, Booser DJ, Esserman L, Lluch A, Vidaurre T, Holmes F, Souchon E, Wang H, Martin M, Cotrina J, Gomez H, Hubbard R, Chacon JI, Ferrer-Lozano J, Dyer R, Buxton M, Gong Y, Wu Y, Ibrahim N, Andreopoulou E, Ueno NT, Hunt K, Yang W, Nazario A, DeMichele A, O\u2019Shaughnessy J, Hortobagyi GN, Symmans WF (2011) A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer. JAMA 305(18):1873\u20131881. https:\/\/doi.org\/10.1001\/jama.2011.593","journal-title":"JAMA"},{"issue":"29","key":"7434_CR46","doi-asserted-by":"publisher","first-page":"3760","DOI":"10.1038\/onc.2014.292","volume":"34","author":"N Andruska","year":"2015","unstructured":"Andruska N, Zheng X, Yang X, Helferich WG, Shapiro DJ (2015) Anticipatory estrogen activation of the unfolded protein response is linked to cell proliferation and poor survival in estrogen receptor alpha-positive breast cancer. Oncogene 34(29):3760\u20133769. https:\/\/doi.org\/10.1038\/onc.2014.292","journal-title":"Oncogene"},{"issue":"12","key":"7434_CR47","doi-asserted-by":"publisher","first-page":"9233","DOI":"10.1007\/s13277-015-3647-0","volume":"36","author":"RD Sicchieri","year":"2015","unstructured":"Sicchieri RD, da Silveira WA, Mandarano LR, de Oliveira TM, Carrara HH, Muglia VF, de Andrade JM, Tiezzi DG (2015) ABCG2 is a potential marker of tumor-initiating cells in breast cancer. Tumour Biol 36(12):9233\u20139243. https:\/\/doi.org\/10.1007\/s13277-015-3647-0","journal-title":"Tumour Biol"},{"issue":"2","key":"7434_CR48","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1158\/1078-0432.CCR-18-1851","volume":"26","author":"HK Angell","year":"2020","unstructured":"Angell HK, Bruni D, Barrett JC, Herbst R, Galon J (2020) The Immunoscore: colon cancer and beyond. Clin Cancer Res 26(2):332\u2013339. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-1851","journal-title":"Clin Cancer Res"},{"issue":"43","key":"7434_CR49","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci 102(43):15545\u201315550. https:\/\/doi.org\/10.1073\/pnas.0506580102","journal-title":"Proc Natl Acad Sci"},{"issue":"4","key":"7434_CR50","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","volume":"48","author":"V Thorsson","year":"2018","unstructured":"Thorsson V, Gibbs DL, Brown SD, Wolf D, Bortone DS, Ou Yang TH, Porta-Pardo E, Gao GF, Plaisier CL, Eddy JA, Ziv E, Culhane AC, Paull EO, Sivakumar IKA, Gentles AJ, Malhotra R, Farshidfar F, Colaprico A, Parker JS, Mose LE, Vo NS, Liu J, Liu Y, Rader J, Dhankani V, Reynolds SM, Bowlby R, Califano A, Cherniack AD, Anastassiou D, Bedognetti D, Mokrab Y, Newman AM, Rao A, Chen K, Krasnitz A, Hu H, Malta TM, Noushmehr H, Pedamallu CS, Bullman S, Ojesina AI, Lamb A, Zhou W, Shen H, Choueiri TK, Weinstein JN, Guinney J, Saltz J, Holt RA, Rabkin CS, Lazar AJ, Cancer Genome Atlas Research N, Serody JS, Demicco EG, Disis ML, Vincent BG, Shmulevich I (2018) The immune landscape of cancer. Immunity 48(4):812\u2013830. https:\/\/doi.org\/10.1016\/j.immuni.2018.03.023","journal-title":"Immunity"},{"issue":"7","key":"7434_CR51","first-page":"3041","volume":"13","author":"M Oshi","year":"2023","unstructured":"Oshi M, Roy AM, Yan L, Sasamoto M, Tokumaru Y, Wu R, Yamada A, Yamamoto S, Chishima T, Narui K, Endo I, Takabe K (2023) Accelerated glycolysis in tumor microenvironment is associated with worse survival in triple-negative but not consistently with ER+\/HER2\u2212 breast cancer. Am J Cancer Res 13(7):3041\u20133054","journal-title":"Am J Cancer Res"},{"issue":"8","key":"7434_CR52","first-page":"3638","volume":"13","author":"K Chida","year":"2023","unstructured":"Chida K, Oshi M, Roy AM, Sato T, Endo I, Takabe K (2023) Pancreatic ductal adenocarcinoma with a high expression of alcohol dehydrogenase 1B is associated with less aggressive features and a favorable prognosis. Am J Cancer Res 13(8):3638\u20133649","journal-title":"Am J Cancer Res"},{"issue":"2","key":"7434_CR53","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.surg.2023.04.030","volume":"174","author":"K Chida","year":"2023","unstructured":"Chida K, Oshi M, Roy AM, Yachi T, Nara M, Yamada K, Matsuura O, Hashizume T, Endo I, Takabe K (2023) E2F target score is associated with cell proliferation and survival of patients with hepatocellular carcinoma. Surgery 174(2):307\u2013314. https:\/\/doi.org\/10.1016\/j.surg.2023.04.030","journal-title":"Surgery"},{"key":"7434_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13061477","author":"M Oshi","year":"2021","unstructured":"Oshi M, Huyser MR, Le L, Tokumaru Y, Yan L, Matsuyama R, Endo I, Takabe K (2021) Abundance of microvascular endothelial cells is associated with response to chemotherapy and prognosis in colorectal cancer. Cancers. https:\/\/doi.org\/10.3390\/cancers13061477","journal-title":"Cancers"},{"issue":"6","key":"7434_CR55","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1053\/j.gastro.2009.12.063","volume":"138","author":"M Todaro","year":"2010","unstructured":"Todaro M, Francipane MG, Medema JP, Stassi G (2010) Colon cancer stem cells: promise of targeted therapy. Gastroenterology 138(6):2151\u20132162. https:\/\/doi.org\/10.1053\/j.gastro.2009.12.063","journal-title":"Gastroenterology"},{"key":"7434_CR56","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12051267","author":"A Ghoneum","year":"2020","unstructured":"Ghoneum A, Gonzalez D, Abdulfattah AY, Said N (2020) Metabolic plasticity in ovarian cancer stem cells. Cancers. https:\/\/doi.org\/10.3390\/cancers12051267","journal-title":"Cancers"},{"issue":"1","key":"7434_CR57","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.radonc.2011.05.067","volume":"101","author":"S Skvortsov","year":"2011","unstructured":"Skvortsov S, Jimenez CR, Knol JC, Eichberger P, Schiestl B, Debbage P, Skvortsova I, Lukas P (2011) Radioresistant head and neck squamous cell carcinoma cells: intracellular signaling, putative biomarkers for tumor recurrences and possible therapeutic targets. Radiother Oncol 101(1):177\u2013182. https:\/\/doi.org\/10.1016\/j.radonc.2011.05.067","journal-title":"Radiother Oncol"},{"key":"7434_CR58","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3389\/fonc.2020.00164","volume":"10","author":"CR Arnold","year":"2020","unstructured":"Arnold CR, Mangesius J, Skvortsova II, Ganswindt U (2020) The Role of cancer stem cells in radiation resistance. Front Oncol 10:164. https:\/\/doi.org\/10.3389\/fonc.2020.00164","journal-title":"Front Oncol"},{"key":"7434_CR59","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/396076","author":"N Moore","year":"2011","unstructured":"Moore N, Lyle S (2011) Quiescent, slow-cycling stem cell populations in cancer: a review of the evidence and discussion of significance. J Oncol. https:\/\/doi.org\/10.1155\/2011\/396076","journal-title":"J Oncol"},{"issue":"21","key":"7434_CR60","doi-asserted-by":"publisher","first-page":"4521","DOI":"10.1002\/pmic.200800113","volume":"8","author":"I Skvortsova","year":"2008","unstructured":"Skvortsova I, Skvortsov S, Stasyk T, Raju U, Popper BA, Schiestl B, von Guggenberg E, Neher A, Bonn GK, Huber LA, Lukas P (2008) Intracellular signaling pathways regulating radioresistance of human prostate carcinoma cells. Proteomics 8(21):4521\u20134533. https:\/\/doi.org\/10.1002\/pmic.200800113","journal-title":"Proteomics"},{"issue":"12","key":"7434_CR61","doi-asserted-by":"publisher","first-page":"7356","DOI":"10.1245\/s10434-021-10063-5","volume":"28","author":"V Satyananda","year":"2021","unstructured":"Satyananda V, Oshi M, Endo I, Takabe K (2021) High BRCA2 gene expression is associated with aggressive and highly proliferative breast cancer. Ann Surg Oncol 28(12):7356\u20137365. https:\/\/doi.org\/10.1245\/s10434-021-10063-5","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"7434_CR62","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1101\/gad.949802","volume":"16","author":"B Ren","year":"2002","unstructured":"Ren B, Cam H, Takahashi Y, Volkert T, Terragni J, Young RA, Dynlacht BD (2002) E2F integrates cell cycle progression with DNA repair, replication, and G(2)\/M checkpoints. Genes Dev 16(2):245\u2013256. https:\/\/doi.org\/10.1101\/gad.949802","journal-title":"Genes Dev"},{"issue":"3","key":"7434_CR63","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/path.4086","volume":"229","author":"P Grosse-Gehling","year":"2013","unstructured":"Grosse-Gehling P, Fargeas CA, Dittfeld C, Garbe Y, Alison MR, Corbeil D, Kunz-Schughart LA (2013) CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challenges. J Pathol 229(3):355\u2013378. https:\/\/doi.org\/10.1002\/path.4086","journal-title":"J Pathol"},{"key":"7434_CR64","doi-asserted-by":"publisher","first-page":"158682","DOI":"10.1155\/2015\/158682","volume":"2015","author":"F Collina","year":"2015","unstructured":"Collina F, Di Bonito M, Li Bergolis V, De Laurentiis M, Vitagliano C, Cerrone M, Nuzzo F, Cantile M, Botti G (2015) Prognostic value of cancer stem cells markers in triple-negative breast cancer. Biomed Res Int 2015:158682. https:\/\/doi.org\/10.1155\/2015\/158682","journal-title":"Biomed Res Int"},{"issue":"16","key":"7434_CR65","doi-asserted-by":"publisher","first-page":"5145","DOI":"10.1158\/1078-0432.CCR-09-0263","volume":"15","author":"AM McCord","year":"2009","unstructured":"McCord AM, Jamal M, Williams ES, Camphausen K, Tofilon PJ (2009) CD133+ glioblastoma stem-like cells are radiosensitive with a defective DNA damage response compared with established cell lines. Clin Cancer Res 15(16):5145\u20135153. https:\/\/doi.org\/10.1158\/1078-0432.CCR-09-0263","journal-title":"Clin Cancer Res"},{"issue":"5","key":"7434_CR66","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1093\/neuonc\/nor010","volume":"13","author":"SC Short","year":"2011","unstructured":"Short SC, Giampieri S, Worku M, Alcaide-German M, Sioftanos G, Bourne S, Lio KI, Shaked-Rabi M, Martindale C (2011) Rad51 inhibition is an effective means of targeting DNA repair in glioma models and CD133+ tumor-derived cells. Neuro Oncol 13(5):487\u2013499. https:\/\/doi.org\/10.1093\/neuonc\/nor010","journal-title":"Neuro Oncol"},{"key":"7434_CR67","doi-asserted-by":"publisher","first-page":"e5530","DOI":"10.7717\/peerj.5530","volume":"6","author":"PL Cheah","year":"2018","unstructured":"Cheah PL, Li J, Looi LM, Teoh KH, Ong DB, Arends MJ (2018) DNA mismatch repair and CD133-marked cancer stem cells in colorectal carcinoma. PeerJ 6:e5530. https:\/\/doi.org\/10.7717\/peerj.5530","journal-title":"PeerJ"},{"issue":"4","key":"7434_CR68","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1158\/2326-6066.CIR-16-0195","volume":"5","author":"AR Green","year":"2017","unstructured":"Green AR, Aleskandarany MA, Ali R, Hodgson EG, Atabani S, De Souza K, Rakha EA, Ellis IO, Madhusudan S (2017) Clinical impact of tumor DNA repair expression and T-cell infiltration in breast cancers. Cancer Immunol Res 5(4):292\u2013299. https:\/\/doi.org\/10.1158\/2326-6066.CIR-16-0195","journal-title":"Cancer Immunol Res"},{"issue":"20","key":"7434_CR69","doi-asserted-by":"publisher","first-page":"3951","DOI":"10.1007\/s00018-014-1666-4","volume":"71","author":"S Yan","year":"2014","unstructured":"Yan S, Sorrell M, Berman Z (2014) Functional interplay between ATM\/ATR-mediated DNA damage response and DNA repair pathways in oxidative stress. Cell Mol Life Sci 71(20):3951\u20133967. https:\/\/doi.org\/10.1007\/s00018-014-1666-4","journal-title":"Cell Mol Life Sci"},{"key":"7434_CR70","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s12974-015-0448-8","volume":"12","author":"B Vuong","year":"2015","unstructured":"Vuong B, Hogan-Cann AD, Alano CC, Stevenson M, Chan WY, Anderson CM, Swanson RA, Kauppinen TM (2015) NF-kappaB transcriptional activation by TNFalpha requires phospholipase C, extracellular signal-regulated kinase 2 and poly(ADP-ribose) polymerase-1. J Neuroinflammation 12:229. https:\/\/doi.org\/10.1186\/s12974-015-0448-8","journal-title":"J Neuroinflammation"},{"key":"7434_CR71","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/1476-4598-12-86","volume":"12","author":"B Hoesel","year":"2013","unstructured":"Hoesel B, Schmid JA (2013) The complexity of NF-kappaB signaling in inflammation and cancer. Mol Cancer 12:86. https:\/\/doi.org\/10.1186\/1476-4598-12-86","journal-title":"Mol Cancer"},{"issue":"8","key":"7434_CR72","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41580-020-0250-z","volume":"21","author":"C Hetz","year":"2020","unstructured":"Hetz C, Zhang K, Kaufman RJ (2020) Mechanisms, regulation and functions of the unfolded protein response. Nat Rev Mol Cell Biol 21(8):421\u2013438. https:\/\/doi.org\/10.1038\/s41580-020-0250-z","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"7434_CR73","first-page":"2627","volume":"12","author":"M Oshi","year":"2022","unstructured":"Oshi M, Roy AM, Gandhi S, Tokumaru Y, Yan L, Yamada A, Endo I, Takabe K (2022) The clinical relevance of unfolded protein response signaling in breast cancer. Am J Cancer Res 12(6):2627\u20132640","journal-title":"Am J Cancer Res"},{"key":"7434_CR74","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20040857","author":"L Sisinni","year":"2019","unstructured":"Sisinni L, Pietrafesa M, Lepore S, Maddalena F, Condelli V, Esposito F, Landriscina M (2019) Endoplasmic reticulum stress and unfolded protein response in breast cancer: the balance between apoptosis and autophagy and its role in drug resistance. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms20040857","journal-title":"Int J Mol Sci"},{"issue":"11","key":"7434_CR75","doi-asserted-by":"publisher","first-page":"e389","DOI":"10.1038\/emm.2017.215","volume":"49","author":"R Minakshi","year":"2017","unstructured":"Minakshi R, Rahman S, Jan AT, Archana A, Kim J (2017) Implications of aging and the endoplasmic reticulum unfolded protein response on the molecular modality of breast cancer. Exp Mol Med 49(11):e389. https:\/\/doi.org\/10.1038\/emm.2017.215","journal-title":"Exp Mol Med"},{"key":"7434_CR76","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21218127","author":"A Schulze","year":"2020","unstructured":"Schulze A, Oshi M, Endo I, Takabe K (2020) MYC Targets scores are associated with cancer aggressiveness and poor survival in ER-positive primary and metastatic breast cancer. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21218127","journal-title":"Int J Mol Sci"},{"issue":"4","key":"7434_CR77","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/BF00573012","volume":"83","author":"I Damjanov","year":"1975","unstructured":"Damjanov I, Katic V, Stevens LC (1975) Ultrastructure of ovarian teratomas in LT mice. Cancer Res Clin Oncol 83(4):261\u2013267. https:\/\/doi.org\/10.1007\/BF00573012","journal-title":"Cancer Res Clin Oncol"},{"issue":"5","key":"7434_CR78","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1634\/stemcells.22-5-716","volume":"22","author":"Z Ivanovic","year":"2004","unstructured":"Ivanovic Z, Hermitte F, Brunet de la Grange P, Dazey B, Belloc F, Lacombe F, Vezon G, Praloran V (2004) Simultaneous maintenance of human cord blood SCID-repopulating cells and expansion of committed progenitors at low O2 concentration (3%). Stem Cells 22(5):716\u2013724. https:\/\/doi.org\/10.1634\/stemcells.22-5-716","journal-title":"Stem Cells"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-024-07434-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-024-07434-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-024-07434-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T17:03:25Z","timestamp":1728147805000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-024-07434-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,17]]},"references-count":78,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["7434"],"URL":"https:\/\/doi.org\/10.1007\/s10549-024-07434-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4148608\/v1","asserted-by":"object"}]},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,17]]},"assertion":[{"value":"22 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"We obtained a waiver of the Roswell Park Institutional Review Board for approval, given the de-identified nature of the data points.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}